2017PubMedRequires access

[Development of Markov models for economics evaluation of strategies on hepatitis B vaccination and population-based antiviral treatment in China].

Pinchao Yang, Shunxiang Zhang, Panpan Sun, Yali Cai, Ying Lin, Yuhua Zou

Open publisher page 5 citations

Abstract

The Markov models developed can be used in economics evaluation of hepatitis B vaccination and treatment for the elimination of HBV infection in China though the structures and parameters in the model have uncertainty with dynamic natures.

About this research paper

What this paper is about

The Markov models developed can be used in economics evaluation of hepatitis B vaccination and treatment for the elimination of HBV infection in China though the structures and parameters in the model have uncertainty with dynamic natures.

Why it matters

OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The Markov models developed can be used in economics evaluation of hepatitis B vaccination and treatment for the elimination of HBV infection in China though the structures and parameters in the model have uncertainty with dynamic natures.

Key concepts: Medicine, HBsAg, Hepatitis B, HBeAg, Population, Hepatitis B virus, Cirrhosis, Immunology

Related papers

Back to paper searchBrowse research topicsOriginal source
[Development of Markov models for economics evaluation of strategies on hepatitis B vaccination and population-based antiviral treatment in China]. — Research Paper | ScholarLens